Next Article in Journal
Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis
Previous Article in Journal
Expanding Role of Contrast-Enhanced Ultrasound and Elastography in the Evaluation of Abdominal Pathologies in Children
Previous Article in Special Issue
Real-World, National Study of Palbociclib in HR+/HER2− Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Deep Learning-Enhanced T1-Weighted Imaging for Breast MRI at 1.5T

1
Department of Diagnostic and Interventional Radiology, University Hospital of Tuebingen, 72076 Tuebingen, Germany
2
Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, 91052 Erlangen, Germany
3
Faculty of Economics and Social Sciences, Institute of Sports Science & Methods Center, University of Tuebingen, 72074 Tuebingen, Germany
4
Cluster of Excellence iFIT (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, 72076 Tuebingen, Germany
*
Author to whom correspondence should be addressed.
Diagnostics 2025, 15(13), 1681; https://doi.org/10.3390/diagnostics15131681
Submission received: 29 May 2025 / Revised: 23 June 2025 / Accepted: 25 June 2025 / Published: 1 July 2025
(This article belongs to the Special Issue Advances in Diagnosis and Prognosis of Breast Cancer)

Abstract

Background/Objectives: Assessment of a novel deep-learning (DL)-based T1w volumetric interpolated breath-hold (VIBEDL) sequence in breast MRI in comparison with standard VIBE (VIBEStd) for image quality evaluation. Methods: Prospective study of 52 breast cancer patients examined at 1.5T breast MRI with T1w VIBEStd and T1 VIBEDL sequence. T1w VIBEDL was integrated as an additional early non-contrast and a delayed post-contrast scan. Two radiologists independently scored T1w VIBE Std/DL sequences both pre- and post-contrast and their calculated subtractions (SUBs) for image quality, sharpness, (motion)–artifacts, perceived signal-to-noise and diagnostic confidence with a Likert-scale from 1: Non-diagnostic to 5: Excellent. Lesion diameter was evaluated on the SUB for T1w VIBEStd/DL. All lesions were visually evaluated in T1w VIBEStd/DL pre- and post-contrast and their subtractions. Statistics included correlation analyses and paired t-tests. Results: Significantly higher Likert scale values were detected in the pre-contrast T1w VIBEDL compared to the T1w VIBEStd for image quality (each p < 0.001), image sharpness (p < 0.001), SNR (p < 0.001), and diagnostic confidence (p < 0.010). Significantly higher values for image quality (p < 0.001 in each case), image sharpness (p < 0.001), SNR (p < 0.001), and artifacts (p < 0.001) were detected in the post-contrast T1w VIBEDL and in the SUB. SUBDL provided superior diagnostic certainty compared to SUBStd in one reader (p = 0.083 or p = 0.004). Conclusions: Deep learning-enhanced T1w VIBEDL at 1.5T breast MRI offers superior image quality compared to T1w VIBEStd.

1. Introduction

Dynamic contrast-enhanced (DCE) breast MRI is the imaging modality with the highest sensitivity for the detection of breast cancer [1]. Therefore, breast MRI plays a crucial role in breast cancer screening in high-risk women with genetic mutations like breast cancer gene (BRCA) 1 or 2 [2], as well as for the local staging in women with biopsy-proven breast cancer [3]. Patients with dense breast tissue, invasive lobular carcinoma, suspected multicentric tumor extent, and potential infiltration of the chest wall benefit from preoperative breast MR [4]. Monitoring the response to neoadjuvant chemotherapy is another key application of breast MRI [5].
The dynamic T1w sequence pre- and post-contrast media application is essential for breast MRI. Subtraction images are calculated, which are mandatory if T1w sequences are acquired without fat suppression [5].
Over the last 30 years, technological development has enabled the application of machine learning in imaging, among other things, to achieve more precise diagnostics, particularly in tumor detection and classification [6,7]. DL as a subfield of machine learning is preferred, as it offers the findings faster and more accurately, as it uses multiple neural networks comparable to human cerebral neurons [6,7,8,9].
Deep learning methods are divided into supervised, unsupervised, and semi-supervised learning models for disease detection and diagnosis [10]. Regarding the supervised models, so far, DL has enabled the detection of asymmetry and skin thickness based on Dynamic Time Warping (DTW) and Growing Region Seed (GRS) for feature extraction in 114 mammograms, including 25 BI-RADS 4® or 5 lesions [11].
The DL application in bilateral tomosynthesis for the detection of parenchymal asymmetry in 115 patients with histologically proven one-sided breast carcinoma was superior to the unilateral trained model [12].
In ultrasound, DL enabled the differentiation of malignant and benign breast lesions by applying a stacked denoising auto-encoder (SDAE) on the computer-aided diagnosis (CAD) in 520 breast examinations, resulting in 245 histologically proven carcinomas [13].
In MRI, DL was able to reduce the biopsy rate by 20% of BI-RADS 4 findings in a study of over 21,000 breast MRIs of over 13,000 patients [14].
Within image evaluation, the DL technique is also applied for image reconstruction in CT and MRI, as well as the post-processing steps, including image enhancement and artefact correction [13,15]. Novel DL reconstruction algorithms have been investigated for faster acquisition time, while significantly improving the image quality for T1w VIBE in the abdomen at 1.5T and 3T and for T2w imaging of the prostate, as well as for diffusion-weighted imaging of the breast (DWI) [16,17,18,19]. Moreover, DL-enhanced sequences are used over a broad range of applications, even down to a field strength of 0.05T, where they enable fast 3D brain MRI [20].
The goal of this study was to compare the image quality of a new T1w VIBE with a DL reconstruction algorithm with conventional VIBE in clinical routine in patients with histologically proven breast cancer undergoing breast MRI.

2. Materials and Methods

2.1. Patient Cohort

This unicenter, prospective study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of our hospital (055/201BO2). All patients with histologically proven breast cancer, examined via breast MRI for clinically indicated, primary staging at our institution, were asked to participate in this prospective study from May 2023 to February 2024. Comparable to other feasibility studies, which analyzed whether DL VIBE provides the required image quality for clinical application, our small study group consisted of 60 patients [16,18,21]. A post hoc sensitivity analysis was conducted in order to detect the minimum detectable population effect size for differences between VIBEStd and VIBEDL using G*Power (version 3.1.9.7; α = 0.05, 1 − β = 0.80, two-tailed). The analyses revealed sufficient sensitivity to detect small-to-moderate differences (d = 0.40).
The study protocol consisted of a T1w VIBEDL sequence pre- and post-contrast media application in addition to the conventional protocol of T2w TIRM and T1w VIBE Std and DL sequences pre- and post-contrast media application. For details on the histological breast cancer subtypes and the tumor size of the patients included in this study, see Figure 1.

2.2. Image Acquisition

All images were acquired with a 1.5T MRI system (MAGNETOM Aera, Siemens Healthineers, Forchheim, Germany). Patients were examined in the prone position with a dedicated seven-channel bilateral breast coil (Siemens Healthineers, Erlangen, Germany) and received a body weight-adapted dose of i.v. Gadovist (Bayer Healthcare, Berlin, Germany; 0.1 mmol gadobutrol/kg body weight). Clinical breast imaging was performed with a T2w fat-suppressed turbo inversion recovery magnitude sequence (T2w TIRM) and non-fat suppressed 3D T1w before and after contrast agent application (T1w VIBEStd TE 4.77 ms, TR 7.73 ms, TA 73s, phase and slice partial Fourier 7/8 and 5/8; T1 VIBEDL TE 4.77 ms, TR 7.69 ms, ETA 73s, phase and slice partial Fourier 6/8 (Table 1)). In addition, a VIBEDL sequence was integrated into the same clinical examination as an early pre-contrast scan and a delayed post-contrast phase to prevent any interference with our clinical imaging standards. The applied DL T1w VIBE technique is a research application package, which was provided by Siemens Healthineers.

2.3. Deep Learning-Accelerated VIBEDL Sequence

Using the inherent image enhancement of a deep learning-based reconstruction, higher accelerated sampling and consequently higher resolution can be achieved by the VIBEDL sequence in the same acquisition time. The reconstruction employs two sequential stages that were developed independently.
In the first stage, images are generated from k-space data on the acquired resolution using a network architecture inspired by unrolled variational networks [22]. The algorithm receives precalculated coil sensitivity maps as well as undersampled k-space data as input and performs six iterations that alternate between parallel imaging-based data consistency and neural network-based image enhancement. Using about 500 fully sampled datasets obtained from healthy volunteers on 1.5T and 3T scanners (MAGNETOM scanners, Siemens Healthineers, Forchheim, Germany) in the head, abdomen, and pelvis, the network was trained end-to-end in a supervised manner with about 5000 derived sub-volumes. Conventional 3D U-nets were chosen as image enhancement networks, the L1-norm was chosen as the loss function, and Adam was chosen as the optimizer. For more details, we refer to Figure 2, which illustrates the network architecture. The obtained model parameters were then integrated into the reconstruction pipeline of the scanner for prospective use. The implementation was previously explored for dynamic liver imaging, with more details given in Ref. [13].
In the second stage, the obtained complex-valued image volumes were non-linearly interpolated by a factor of two in all spatial directions using a deep learning-based super-resolution algorithm. For supervised training using a similar dataset as employed for the first stage, the input data were generated through retrospective downsampling, and partial Fourier sampling, corresponding to the prospective acquisition, was simulated in the Fourier domain. Consequently, the obtained model parameters were tailored to the selected partial Fourier settings. Similar to the k-space reconstruction, these parameters were integrated into the reconstruction pipeline of the scanner, and we refer to Refs. [6,8] for more details.
The overall deep learning-based image reconstruction was provided by Siemens Healthineers as a research application.

2.4. Image Analysis

Image analysis was performed on the pre-contrast scans of T1w VIBEStd and T1w VIBEDL, the latest available post-contrast scan for both sequences, and corresponding subtractions (SUBs) by two radiologists (H.P. with 13 years and S-C.O. with 7 years of experience in reading breast MRI). Although the latest post-contrast scans for T1w VIBEStd are not the most clinically relevant, these time points were chosen for the analysis, as they provide the closest time match to the delayed post-contrast phase of T1w VIBEDL.
For lesion analysis, only biopsy-proven malignant lesions were examined. A total of 49 of the 52 included patients were surgically treated in-house, and histopathological specimens were analyzed at our local histopathology institute (for further details, see Figure 1). Benign lesions (n = 1) were omitted from the analysis.
Each reader evaluated the pre- and post-contrast media images as well as the calculated SUB for T1w VIBEStd and DL sequences qualitatively in our standard postprocessing software (syngo.via, 9.4, Siemens Healthineers, Erlangen, Germany). Qualitative image evaluation was based on a five-point Likert scale (with 1 for non-diagnostic imaging, 2 for poor, 3 for moderate, 4 for good, and 5 for excellent) for motion artefacts, image quality, artefacts, sharpness, signal-to-noise ratio (SNR), and diagnostic confidence. Motion artefacts included those caused by breathing, which cannot be excluded effectively even with craniocaudal fixation of the breast.
Diagnostic confidence of the unsubtracted pre- and post-contrast T1w VIBEDL and Std sequence referred to the visibility of the tumor lesion in those non-diagnostic images for the study purpose of image quality evaluation.
Quantitative analysis included the diameter of the malignant lesion in T1w VIBE Std and T1w VIBE DL compared to our gold standard, the 2nd SUB of T1w VIBEStd.

2.5. Statistical Analysis

SPSS (version 28, IBM, Chicago, IL, USA) was used for statistical calculations. The determination of the interrater reliability was analyzed based on contingency tables and the resulting percentage of agreement between raters, as the utilized Likert scales were often not fully utilized and, thus, the calculation of correlation values does not provide meaningful results. Outcome differences between VIBEStd and VIBEDL were determined via paired t-tests. Results with p-values of ≤0.05 were considered statistically significant.

3. Results

3.1. Patients

Of the 60 patients who gave written informed consent, 1 patient had histologically proven benign disease (adenosis) and another 7 patients had incomplete imaging results (Figure 1). The mean age of the 52 female patients included in this study was 55.7 years (SD 22.1 years).

3.2. Qualitative Image Evaluation

3.2.1. Qualitative Image Evaluation for T1w VIBE Pre-Contrast

T1w VIBEDL revealed superior image quality compared to T1w VIBEStd for the image sharpness and SNR, as well as a higher diagnostic confidence in both readers (Table 2; all p ≤ 0.05). One reader detected significantly more artefacts in T1w VIBEDL compared to T1w VIBEStd, without affecting the diagnostic confidence (p < 0.001), however. Motion artefacts were comparable in T1w VIBEStd and the new T1w VIBEDL in both readers (p > 0.99 and p = 0.322, respectively). The percentage of agreement between raters ranged between 38% for artefacts and 96% for the evaluation of motion artefacts (Table 2).

3.2.2. Qualitative Image Evaluation for T1w VIBE Post-Contrast

T1w VIBEDL offered superior results compared to T1w VIBEStd for image quality, sharpness, and the SNR in both readers (p < 0.001, Table 3). Also, the diagnostic confidence was rated superior in T1w VIBEDL compared to T1w VIBEStd in one reader (p = 0.001). Regarding the motion artefacts, no significant differences between the two sequences were noted in both readers (p = 0.261 and p = 0.322, respectively). However, a significantly higher number of image artefacts were detected in T1w VIBEDL compared to the Std sequence in both readers (p < 0.001, respectively). The percentage of agreement between raters ranged from 51% for reader 1 for sharpness and up to 92% for reader 1 regarding the motion artefacts.

3.3. Qualitative Image Evaluation for Post-Contrast Subtraction Images (SUB)

T1 VIBE subtraction images of the T1w VIBEDL (SUBs) showed superior results compared to the SUB of T1w VIBEStd for image quality, sharpness, and the SNR in both readers (p < 0.001; Table 3, Figure 3). Diagnostic confidence was also rated significantly superior in one reader (p = 0.004). Motion artefacts were comparable between T1w VIBEDL and Std in both readers (p = 0.103 and 0.766). However, significantly more artifacts in the mediastinum apart from the diagnostic relevant area were detected in the SUBs of T1w VIBEDL compared to Std in both readers (p < 0.001; Figure 4). The percentage of agreement between raters ranged from 34% for artefacts in reader 2 and 91% for diagnostic confidence in reader 2 (Table 4).

3.4. Quantitative Image Evaluation: Lesion Visibility and Diameter

The primary tumor was visible in 50/52 T1w VIBEStd and T1w VIBEDL pre- and post-contrast scans. In the diagnostic relevant SUB of T1w VIBEStd and DL sequences. All 52 histologically proven tumors were visible.
Compared to the gold standard of the 2nd T1w SUB after contrast media application, the lesion diameter was comparable in SUBStd and SUBDL (mean SUBStd 26.71, mean SUBDL 26.63 for reader 1 and mean SUBStd 30.89, SUBDL 30.04 for reader 2; Table 5).

4. Discussion

Application of this new DL-based T1w VIBE in breast MRI at 1.5T led to superior image quality, sharpness, and SNR for both readers in all sequences with the same acquisition time of 73 s compared with the T1w VIBEStd sequence. The DL technique reduces the noise, leading to a higher SNR, especially in lower-field strengths like 1.5T. In this study, DL-based T1w VIBE was employed to increase imaging quality, defined by higher resolution, while the scan time was kept unaltered to enable a comparable contrast media kinetics evaluation of the lesions. DL also enables a reduction in acquisition time while maintaining the SNR. However, this was not the case in this study as the contrast dynamics set the temporal scale.
As DL sequences provide denoised images, structures usually hidden by noise—like motion or aliasing artifacts—may become more pronounced [23]. In our study, comparable motion artefacts were detected for T1w VIBEDL und T1w VIBEStd. However, our results reflect significantly more artefacts in T1w VIBEDL pre- and post-contrast media application and the calculated SUB compared to the Std sequences. As the artefacts were detected in the mediastinum distant to the relevant images of the breast, diagnostic confidence was not affected.
As we performed T1w VIBEDL sequences in addition to our clinical imaging standard, T1w VIBEDL sequences were obtained at the end of the examination to provide our patients with the standard diagnostic image quality. Consequently, we compared the SUB of the last acquired T1w VIBEStd with the SUB of T1 VIBEDL, in recognition of a higher number of motion artefacts in both sequences.
In our study, neither missed nor additional lesions in DL sequences pre-contrast and the diagnostically relevant SUB could be detected compared to standard sequences. In two patients, the tumor was not visible in the non-diagnostic unsubtracted T1w VIBE after contrast media application, affecting both the late Std and the DL T1w VIBE sequence without influencing the diagnostically relevant (early) SUB, however. Significantly higher detection rates of small liver lesions under 2 cm were reported in a study of DL controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) VIBE compared to the standard T1w VIBE in the hepatobiliary phase in 168 patients in the study by Wei et al. [24]. In this study, the DL sequences appeared to have a synthetic appearance.

4.1. Limitations

Limitations of this study encompass the relatively small study cohort of histologically proven breast cancer patients with different tumor entities. In the future, this sequence must be tested on larger patient cohorts, potentially with different histopathological subgroups. However, this study was planned as a feasibility study, providing the basis for additional studies in the future.
Furthermore, as mentioned in several other studies, we applied this new MR sequence to a private dataset at our institution at 1.5T. Broader examination using different scanners and field strengths should be performed in the future to prove the reproducibility [8,9].
Finally, we noticed a variation in the interrater reliability, limiting the objectivity of the visual analysis. Consequently, further studies should focus on the objective quantitative kinetic curve analysis. However, the effect of DL on dynamic contrast-enhanced MR analysis is still unclear [23].

4.2. Scientific Contribution

This study shows that this new DL T1w sequence in breast MR imaging at 1.5T provides superior image quality compared to conventional T1w sequences in clinical routine settings in a small prospectively examined study cohort of patients with histologically proven breast cancer.
The authors of a previous study investigated an accelerated high-resolution T1-weighted breast MR sequence with DL super-resolution reconstruction [25]. Analyzing 47 patients, they observed a higher overall image quality, SNR, and contrast-to-noise ratio (CNR) while reducing acquisition time by 51%. There was no loss in resolution due to super-resolution interpolation. The T1w VIBEDL we used in our study uses the same acquisition time, compared to T1w VIBEStd, and a gain in resolution is reached through super-resolution interpolation. An increased resolution is not only favorable in a collective of patients with biopsy-proven breast cancer but also in a high-risk screening collective. The aim of intensified surveillance in high-risk women, for example, is to find cancers at an early stage, and therefore, the detection of very small suspicious lesions is of great clinical importance.
The results of this study strengthen the role of DL in the future, that DL has not only the potential to decrease acquisition time but to also improve image quality without increasing acquisition time and therefore patients’ benefit from breast MR examination.

5. Conclusions

Deep learning-based T1w VIBE offers superior image quality in clinical routine at 1.5T compared to conventional T1w VIBE. Although T1w VIBEDL was associated with significantly more artefacts, diagnostic confidence was not impaired, as the artefacts occurred in the mediastinum.

Author Contributions

Conceptualization, S.-C.O., S.A. and H.P.; methodology, S.-C.O., D.L., S.A. and H.P.; software, M.D.N. and E.W.; validation, S.-C.O., D.L. and H.P.; formal analysis, S.-C.O. and H.P.; investigation, S.-C.O., D.L. and H.P.; resources, M.D.N., E.W., S.A. and K.N.; data curation, S.-C.O. and H.P.; writing—original draft preparation, S.-C.O.; writing—review and editing, S.-C.O., M.D.N., E.W., D.L., K.N. and H.P.; visualization, S.-C.O. and M.D.N.; supervision, K.N.; project administration, S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Tuebingen (protocol code IRB; No 055/2017BO2 and date of approval 16 November 2022).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available from the corresponding author upon request due to legal reasons.

Conflicts of Interest

Authors Marcel Dominik Nickel and Elisabeth Weiland were employed by the company Siemens Healthineers AG, Forchheim, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BI-RADSBreast Imaging Reporting and Data System
BRCABreast cancer gene
CAIPIRINHAControlled aliasing in parallel imaging results in higher acceleration
CNRContrast-to-noise ratio
DLDeep learning
DCISDuctal carcinoma in situ
DCE MRIDynamic contrast-enhanced MRI
EUSOBIEuropean Society of Breast Imaging
ILCInvasive lobular breast carcinoma
NSTNo special type
ROIRegion of interest
SNRSignal–to-noise ratio
SUBSubtraction
TAAcquisition time
TEEcho time
TRRepetition time
VIBEVolumetric interpolated breath-hold
WWeighted
WIPWork-in-progress

References

  1. Mann, R.M.; Balleyguier, C.; Baltzer, P.A.; Bick, U.; Colin, C.; Cornford, E.; Evans, A.; Fallenberg, E.; Forrai, G.; Fuchsjager, M.H.; et al. Breast MRI: EUSOBI recommendations for women’s information. Eur. Radiol. 2015, 25, 3669–3678. [Google Scholar] [CrossRef] [PubMed]
  2. Mann, R.M.; Kuhl, C.K.; Moy, L. Contrast-enhanced MRI for breast cancer screening. J. Magn. Reson. Imaging 2019, 50, 377–390. [Google Scholar] [CrossRef]
  3. Sharma, S.; Vicenty-Latorre, F.G.; Elsherif, S.; Sharma, S. Role of MRI in Breast Cancer Staging: A Case-Based Review. Cureus 2021, 13, e20752. [Google Scholar] [CrossRef] [PubMed]
  4. Teichgraeber, D.C.; Guirguis, M.S.; Whitman, G.J. Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual, 8th Edition, and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging. Am. J. Roentgenol. 2021, 217, 278–290. [Google Scholar] [CrossRef] [PubMed]
  5. Mann, R.M.; Cho, N.; Moy, L. Breast MRI: State of the Art. Radiology 2019, 292, 520–536. [Google Scholar] [CrossRef]
  6. Radak, M.; Lafta, H.Y.; Fallahi, H. Machine learning and deep learning techniques for breast cancer diagnosis and classification: A comprehensive review of medical imaging studies. J. Cancer Res. Clin. Oncol. 2023, 149, 10473–10491. [Google Scholar] [CrossRef]
  7. Le, E.P.V.; Wang, Y.; Huang, Y.; Hickman, S.; Gilbert, F.J. Artificial intelligence in breast imaging. Clin. Radiol. 2019, 74, 357–366. [Google Scholar] [CrossRef]
  8. Din, N.M.U.; Dar, R.A.; Rasool, M.; Assad, A. Breast cancer detection using deep learning: Datasets, methods, and challenges ahead. Comput. Biol. Med. 2022, 149, 106073. [Google Scholar] [CrossRef]
  9. Jiang, B.; Bao, L.; He, S.; Chen, X.; Jin, Z.; Ye, Y. Deep learning applications in breast cancer histopathological imaging: Diagnosis, treatment, and prognosis. Breast Cancer Res. 2024, 26, 137. [Google Scholar] [CrossRef]
  10. Chen, Z.; Pawar, K.; Ekanayake, M.; Pain, C.; Zhong, S.; Egan, G.F. Deep Learning for Image Enhancement and Correction in Magnetic Resonance Imaging-State-of-the-Art and Challenges. J. Digit. Imaging 2023, 36, 204–230. [Google Scholar] [CrossRef]
  11. Bayareh-Mancilla, R.; Medina-Ramos, L.A.; Toriz-Vazquez, A.; Hernandez-Rodriguez, Y.M.; Cigarroa-Mayorga, O.E. Automated Computer-Assisted Medical Decision-Making System Based on Morphological Shape and Skin Thickness Analysis for Asymmetry Detection in Mammographic Images. Diagnostics 2023, 13, 3440. [Google Scholar] [CrossRef] [PubMed]
  12. Shimokawa, D.; Takahashi, K.; Kurosawa, D.; Takaya, E.; Oba, K.; Yagishita, K.; Fukuda, T.; Tsunoda, H.; Ueda, T. Deep learning model for breast cancer diagnosis based on bilateral asymmetrical detection (BilAD) in digital breast tomosynthesis images. Radiol. Phys. Technol. 2023, 16, 20–27. [Google Scholar] [CrossRef] [PubMed]
  13. Cheng, J.Z.; Ni, D.; Chou, Y.H.; Qin, J.; Tiu, C.M.; Chang, Y.C.; Huang, C.S.; Shen, D.; Chen, C.M. Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans. Sci. Rep. 2016, 6, 24454. [Google Scholar] [CrossRef] [PubMed]
  14. Witowski, J.; Heacock, L.; Reig, B.; Kang, S.K.; Lewin, A.; Pysarenko, K.; Patel, S.; Samreen, N.; Rudnicki, W.; Luczynska, E.; et al. Improving breast cancer diagnostics with deep learning for MRI. Sci. Transl. Med. 2022, 14, eabo4802. [Google Scholar] [CrossRef]
  15. Yaqub, M.; Jinchao, F.; Arshid, K.; Ahmed, S.; Zhang, W.; Nawaz, M.Z.; Mahmood, T. Deep Learning-Based Image Reconstruction for Different Medical Imaging Modalities. Comput. Math. Methods Med. 2022, 2022, 8750648. [Google Scholar] [CrossRef]
  16. Chaika, M.; Afat, S.; Wessling, D.; Afat, C.; Nickel, D.; Kannengiesser, S.; Herrmann, J.; Almansour, H.; Mannlin, S.; Othman, A.E.; et al. Deep learning-based super-resolution gradient echo imaging of the pancreas: Improvement of image quality and reduction of acquisition time. Diagn. Interv. Imaging 2022, 104, 53–59. [Google Scholar] [CrossRef]
  17. Wessling, D.; Gassenmaier, S.; Olthof, S.C.; Benkert, T.; Weiland, E.; Afat, S.; Preibsch, H. Novel deep-learning-based diffusion weighted imaging sequence in 1.5 T breast MRI. Eur. J. Radiol. 2023, 166, 110948. [Google Scholar] [CrossRef]
  18. Almansour, H.; Herrmann, J.; Gassenmaier, S.; Lingg, A.; Nickel, M.D.; Kannengiesser, S.; Arberet, S.; Othman, A.E.; Afat, S. Combined Deep Learning-based Super-Resolution and Partial Fourier Reconstruction for Gradient Echo Sequences in Abdominal MRI at 3 Tesla: Shortening Breath-Hold Time and Improving Image Sharpness and Lesion Conspicuity. Acad. Radiol. 2023, 30, 863–872. [Google Scholar] [CrossRef]
  19. Gassenmaier, S.; Warm, V.; Nickel, D.; Weiland, E.; Herrmann, J.; Almansour, H.; Wessling, D.; Afat, S. Thin-Slice Prostate MRI Enabled by Deep Learning Image Reconstruction. Cancers 2023, 15, 578. [Google Scholar] [CrossRef]
  20. Man, C.; Lau, V.; Su, S.; Zhao, Y.; Xiao, L.; Ding, Y.; Leung, G.K.K.; Leong, A.T.L.; Wu, E.X. Deep learning enabled fast 3D brain MRI at 0.055 tesla. Sci. Adv. 2023, 9, eadi9327. [Google Scholar] [CrossRef]
  21. Brendel, J.M.; Jacoby, J.; Dehdab, R.; Ursprung, S.; Fritz, V.; Werner, S.; Herrmann, J.; Brendlin, A.S.; Gassenmaier, S.; Schick, F.; et al. Prospective Deployment of Deep Learning Reconstruction Facilitates Highly Accelerated Upper Abdominal MRI. Acad. Radiol. 2024, 31, 4965–4973. [Google Scholar] [CrossRef] [PubMed]
  22. Hammernik, K.; Klatzer, T.; Kobler, E.; Recht, M.P.; Sodickson, D.K.; Pock, T.; Knoll, F. Learning a variational network for reconstruction of accelerated MRI data. Magn. Reson. Med. 2018, 79, 3055–3071. [Google Scholar] [CrossRef] [PubMed]
  23. Kiryu, S.; Akai, H.; Yasaka, K.; Tajima, T.; Kunimatsu, A.; Yoshioka, N.; Akahane, M.; Abe, O.; Ohtomo, K. Clinical Impact of Deep Learning Reconstruction in MRI. Radiographics 2023, 43, e220133. [Google Scholar] [CrossRef] [PubMed]
  24. Wei, H.; Yoon, J.H.; Jeon, S.K.; Choi, J.W.; Lee, J.; Kim, J.H.; Nickel, M.D.; Song, B.; Duan, T.; Lee, J.M. Enhancing gadoxetic acid-enhanced liver MRI: A synergistic approach with deep learning CAIPIRINHA-VIBE and optimized fat suppression techniques. Eur. Radiol. 2024, 34, 6712–6725. [Google Scholar] [CrossRef]
  25. Mesropyan, N.; Katemann, C.; Leutner, C.; Sommer, A.; Isaak, A.; Weber, O.M.; Peeters, J.M.; Dell, T.; Bischoff, L.; Kuetting, D.; et al. Accelerated High-resolution T1- and T2-weighted Breast MRI with Deep Learning Super-resolution Reconstruction. Acad. Radiol. 2025, 32, 3147–3156. [Google Scholar] [CrossRef]
Figure 1. Overview of the entire study cohort examined via 1.5T breast MRI with T1 VIBE Standard (Std) and T1 VIBE deep learning (DL). No special type (NST); ductal carcinoma in situ (DCIS).
Figure 1. Overview of the entire study cohort examined via 1.5T breast MRI with T1 VIBE Standard (Std) and T1 VIBE deep learning (DL). No special type (NST); ductal carcinoma in situ (DCIS).
Diagnostics 15 01681 g001
Figure 2. Flowchart of the reconstruction process using undersampled k-space data as well as precalculated coil sensitivity maps as input, performing the image generation through six iterations that alternate between a parallel imaging model and a network-based image enhancement, and finally interpolating the image using a deep learning-based super-resolution tailored to the selected partial Fourier sampling in the acquisition. Furthermore, the conventional 3D U-net architecture used in each iteration is detailed with the employed hyperparameters.
Figure 2. Flowchart of the reconstruction process using undersampled k-space data as well as precalculated coil sensitivity maps as input, performing the image generation through six iterations that alternate between a parallel imaging model and a network-based image enhancement, and finally interpolating the image using a deep learning-based super-resolution tailored to the selected partial Fourier sampling in the acquisition. Furthermore, the conventional 3D U-net architecture used in each iteration is detailed with the employed hyperparameters.
Diagnostics 15 01681 g002
Figure 3. Patient with histologically proven no-special type (NST) breast carcinoma G2 on the left side, with a lesion diameter of 45mm (pT2). Compared to T1 VIBEStd pre-contrast (a), post-contrast (c), and the last SUB (e), the T1 VIBEDL pre-contrast (b), post-contrast (d), and the SUB (f) display the tumor with higher sharpness, without affecting diagnostic confidence. Based on the evaluation of the latest SUB, there are relevant motion artifacts in T1 VIBE SUBStd and DL, based on the study design.
Figure 3. Patient with histologically proven no-special type (NST) breast carcinoma G2 on the left side, with a lesion diameter of 45mm (pT2). Compared to T1 VIBEStd pre-contrast (a), post-contrast (c), and the last SUB (e), the T1 VIBEDL pre-contrast (b), post-contrast (d), and the SUB (f) display the tumor with higher sharpness, without affecting diagnostic confidence. Based on the evaluation of the latest SUB, there are relevant motion artifacts in T1 VIBE SUBStd and DL, based on the study design.
Diagnostics 15 01681 g003
Figure 4. Patient with histologically proven invasive lobular breast carcinoma (ILC) G2 on the left side. Tumor margins are sharper in T1 VIBEDL (b) compared to T1 VIBEStd (a) in pre-contrast images. No tumor assessment is possible in non-diagnostic post-contrast images in T1 VIBEStd and DL (c,d). The tumor is displayed sharply in T1 VIBE SUBDL compared to T1 VIBE SUBStd (e,f), while more artefacts outside the area of interest were detected in T1 VIBEDL, e.g., in the mediastinum (g,h).
Figure 4. Patient with histologically proven invasive lobular breast carcinoma (ILC) G2 on the left side. Tumor margins are sharper in T1 VIBEDL (b) compared to T1 VIBEStd (a) in pre-contrast images. No tumor assessment is possible in non-diagnostic post-contrast images in T1 VIBEStd and DL (c,d). The tumor is displayed sharply in T1 VIBE SUBDL compared to T1 VIBE SUBStd (e,f), while more artefacts outside the area of interest were detected in T1 VIBEDL, e.g., in the mediastinum (g,h).
Diagnostics 15 01681 g004
Table 1. Overview of the protocol parameters of T1 VIBEStd and T1 VIBEDL.
Table 1. Overview of the protocol parameters of T1 VIBEStd and T1 VIBEDL.
Protocol ParameterT1 VIBEStdT1 VIBEDL
Resolution0.9 × 0.9 × 2.0 mm30.4 (i) × 0.4 (i) × 2.0 mm3
Matrix448544
FOV420 × 420 mm2420 × 420 mm2
TA/scan73 s73 s
Number of scans (Pre-/post-contrast)1/71/1
TR/TE7.73/4.77 ms7.69/4.77 ms
Fat saturationNoneNone
Parallel imaging factor22
Partial Fourier (phase, slice)7/8, 5/86/8, 6/8
Reconstruction modeCAIPIRINHADL enhanced
CAIPIRINHA with partial Fourier optimized
super-resolution
Table 2. Results of the analysis of pre-contrast scans for T1 VIBEStd and T1 VIBEDL. IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Table 2. Results of the analysis of pre-contrast scans for T1 VIBEStd and T1 VIBEDL. IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Reader 1 Reader 2Percentage of Agreement Between Raters
Image Parameters
T1 VIBE Sequence
Precontrast
T1 VIBEStd
Mean (SD)
T1 VIBEDL
Mean (SD)
p-ValueT1 VIBEStd
Mean (SD)
T1 VIBEDL
Mean (SD)
p-ValueT1
VIBEStd
T1
VIBEDL
Motion artefacts4.96
(0.19)
4.96
(0.02)
>0.994.98
(0.13)
4.96
(0.19)
0.32294%96%
Image quality (IQ)4.17
(0.61)
4.91
(0.35)
<0.0013.98
(0.13)
5.00
(0.00)
<0.00160%92%
Artefacts4.96
(0.19)
5.000
(0.00)
0.1594.75
(0.43)
4.30
(0.60)
<0.00172%38%
Sharpness3.47
(0.54)
4.71
(0.57)
<0.0013.04
(0.28)
4.98
(0.14)
<0.00151%76%
SNR4.02
(0.58)
4.78
(0.57)
<0.0014.00
(0.34)
4.92
(0.03)
<0.00159%84%
DC4.51
(0.78)
4.67
(0.73)
0.0044.39
(0.69)
4.61
(0.56)
0.00161%71%
Table 3. Results of the analysis of post-contrast scans for T1 VIBEStd and T1 VIBEDL. * not available, as the difference between T1 VIBEStd and T1 VIBEDL for image quality is constantly calculated with 1. IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Table 3. Results of the analysis of post-contrast scans for T1 VIBEStd and T1 VIBEDL. * not available, as the difference between T1 VIBEStd and T1 VIBEDL for image quality is constantly calculated with 1. IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Reader 1 Reader 2Percentage of Agreement Between Raters
Image Parameters
T1 VIBE Sequence
Postcontrast
T1
VIBEStd
Mean (SD)
T1 VIBEDL
Mean (SD)
p-
Value
T1
VIBEStd
Mean
(SD)
T1 VIBEDL
Mean
(SD)
p-
Value
T1
VIBEStd
T1 VIBEDL
Motion
artefacts
4.94
(0.23)
4.89
(0.42)
0.2614.98
(0.13)
4.96
(0.19)
0.32292%87%
Image
quality (IQ)
4.04
(0.55)
4.75
(0.51)
<0.0013.98
(0.13)
4.98
(0.13)
*68%77%
Artefacts4.81
(0.39)
4.25
(0.55)
<0.0014.75
(0.43)
4.30
(0.60)
<0.00153%70%
Sharpness3.55
(0.57)
4.71
(0.64)
<0.0013.06
(0.31)
4.92
(0.33)
<0.00151%76%
SNR4.65
(0.60)
4.43
(0.74)
<0.0014.06
(0.23)
4.92
(0.27)
<0.00167%75%
DC4.43
(0.80)
4.53
(0.83)
0.0584.59
(0.72)
4.82
(0.43)
0.00163%76%
Table 4. Results of the SUB for T1 VIBEStd and T1 VIBEDL (Note: The latest available post-contrast scan was always used for the subtraction). SUB = subtraction; IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Table 4. Results of the SUB for T1 VIBEStd and T1 VIBEDL (Note: The latest available post-contrast scan was always used for the subtraction). SUB = subtraction; IQ = image quality; SNR = signal-to-noise ratio; DC = diagnostic confidence.
Reader 1 Reader 2Percentage of Agreement Between Raters
Image Parameters
T1 VIBE SUB
T1 VIBEStd
Mean
(SD)
T1 VIBEDL
Mean
(SD)
p-ValueT1 VIBEStd
Mean
(SD)
T1 VIBEDL
Mean
(SD)
p-ValueT1 VIBEStdT1 VIBEDL
Motion artefacts4.25
(0.67)
4.09
(0.79)
0.104.02
(0.36)
4.00
(0.39)
0.76655%49%
Image quality (IQ)3.79
(0.66)
4.58
(0.71)
<0.0013.94
(0.30)
4.45
(0.63)
<0.00170%40%
Artefacts4.83
(0.42)
4.36
(0.73)
<0.0014.58
(0.49)
4.19
(0.55)
<0.00147%34%
Sharpness3.57
(0.60)
4.83
(0.612)
<0.0013.11
(0.32)
4.89
(0.37)
<0.00143%85%
SNR4.17
(0.70)
4.83
(0.61)
<0.0013.98
(0.23)
4.70
(0.54)
<0.00153%66%
DC4.79
(0.68)
4.85
(0.63)
0.0834.77
(0.46)
4.92
(0.26)
0.00481%91%
Table 5. Overview of the lesion size in reader 1 and 2.
Table 5. Overview of the lesion size in reader 1 and 2.
Lesion Size in mm (Std)Mean Value
Reader 1
Mean Value
Reader 2
SUB VIBEStd26.71 (25.09)30.89 (26.64)
SUB VIBEDL26.63 (25.00)30.04 (26.65)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Olthof, S.-C.; Nickel, M.D.; Weiland, E.; Leyhr, D.; Afat, S.; Nikolaou, K.; Preibsch, H. Deep Learning-Enhanced T1-Weighted Imaging for Breast MRI at 1.5T. Diagnostics 2025, 15, 1681. https://doi.org/10.3390/diagnostics15131681

AMA Style

Olthof S-C, Nickel MD, Weiland E, Leyhr D, Afat S, Nikolaou K, Preibsch H. Deep Learning-Enhanced T1-Weighted Imaging for Breast MRI at 1.5T. Diagnostics. 2025; 15(13):1681. https://doi.org/10.3390/diagnostics15131681

Chicago/Turabian Style

Olthof, Susann-Cathrin, Marcel Dominik Nickel, Elisabeth Weiland, Daniel Leyhr, Saif Afat, Konstantin Nikolaou, and Heike Preibsch. 2025. "Deep Learning-Enhanced T1-Weighted Imaging for Breast MRI at 1.5T" Diagnostics 15, no. 13: 1681. https://doi.org/10.3390/diagnostics15131681

APA Style

Olthof, S.-C., Nickel, M. D., Weiland, E., Leyhr, D., Afat, S., Nikolaou, K., & Preibsch, H. (2025). Deep Learning-Enhanced T1-Weighted Imaging for Breast MRI at 1.5T. Diagnostics, 15(13), 1681. https://doi.org/10.3390/diagnostics15131681

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop